Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?

David SP.

Addiction. 2014 Jan;109(1):138-9. doi: 10.1111/add.12390. No abstract available.

PMID:
24438115
2.

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

Chen LS, Bloom AJ, Baker TB, Smith SS, Piper ME, Martinez M, Saccone N, Hatsukami D, Goate A, Bierut L.

Addiction. 2014 Jan;109(1):128-37. doi: 10.1111/add.12353.

3.

[Bupropion. An antidepressant used to help smoking cessation].

Taeron C.

Rev Infirm. 2002 May;(81):47-9. French. No abstract available.

PMID:
12078615
4.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.

Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232.

5.

Smoking cessation.

Rennard SI, Daughton DM.

Clin Chest Med. 2014 Mar;35(1):165-76. doi: 10.1016/j.ccm.2013.11.002. Review.

PMID:
24507844
6.

Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.

Saxon AJ, Baer JS, Davis TM, Sloan KL, Malte CA, Fitzgibbons K, Kivlahan DR.

Nicotine Tob Res. 2003 Aug;5(4):589-96.

PMID:
12959797
7.

The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.

Japuntich SJ, Piper ME, Leventhal AM, Bolt DM, Baker TB.

J Consult Clin Psychol. 2011 Feb;79(1):34-42. doi: 10.1037/a0022154.

8.

Medications for smoking cessation.

Corelli RL, Hudmon KS.

West J Med. 2002 Mar;176(2):131-5. Review. No abstract available.

9.

[Bupropion; an effective new aid for smoking cessation].

Burgers JS, van der Laan JR.

Ned Tijdschr Geneeskd. 2001 Feb 10;145(6):285-6. Dutch. No abstract available.

PMID:
11236376
10.

Does bupropion have advantages over other medical therapies in the cessation of smoking?

Tonstad S, Johnston JA.

Expert Opin Pharmacother. 2004 Apr;5(4):727-34. Review.

PMID:
15102559
11.

The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, Raftery JP, Aveyard PN, Hyde CJ, Barton PM.

Health Technol Assess. 2002;6(16):1-245. Review. No abstract available.

12.

Effectiveness of bupropion for smoking cessation during pregnancy.

Chan B, Einarson A, Koren G.

J Addict Dis. 2005;24(2):19-23.

PMID:
15784520
13.

The use of bupropion hydrochloride for smoking cessation therapy.

Nichols MR.

Clin Excell Nurse Pract. 1999 Nov;3(6):317-22. Review.

PMID:
10865568
14.

Bupropion for smoking cessation in patients with acute coronary syndrome.

Planer D, Lev I, Elitzur Y, Sharon N, Ouzan E, Pugatsch T, Chasid M, Rom M, Lotan C.

Arch Intern Med. 2011 Jun 27;171(12):1055-60. doi: 10.1001/archinternmed.2011.72.

PMID:
21403011
15.

Non-nicotine pharmacotherapies for smoking cessation.

McRobbie H, Lee M, Juniper Z.

Respir Med. 2005 Oct;99(10):1203-12. Review.

16.
17.

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.

Stapleton J, West R, Hajek P, Wheeler J, Vangeli E, Abdi Z, O'Gara C, McRobbie H, Humphrey K, Ali R, Strang J, Sutherland G.

Addiction. 2013 Dec;108(12):2193-201. doi: 10.1111/add.12304.

18.

Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?

Verde Z, Santiago C, Rodríguez González-Moro JM, de Lucas Ramos P, López Martín S, Bandrés F, Lucia A, Gómez-Gallego F.

Pharmacopsychiatry. 2014 Jan;47(1):33-6. doi: 10.1055/s-0033-1358393.

PMID:
24127329
19.

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2007;47:541-64. Review.

PMID:
17209799
20.

Enhancing the effectiveness of smoking cessation interventions: a cancer prevention imperative.

Alberg AJ, Carpenter MJ.

J Natl Cancer Inst. 2012 Feb 22;104(4):260-2. doi: 10.1093/jnci/djr558. No abstract available.

Supplemental Content

Support Center